Spend your FSA balance before it expires: Many workers 'aren't aware that they have a deadline,' expert says

A large share of employees — roughly 40%–50% annually — forfeit unused health flexible spending account (FSA) balances, with the average forfeiture $436 in 2023, because about two-thirds of employers enforce a use-it-or-lose-it rule. Policy and usage details matter: 72% of state/local and 47% of private-sector workers had FSA access in 2024; contribution limits are $3,300 in 2024 and $3,400 in 2026; employers may offer either a 2.5-month grace period or carryover up to $660 (not both), and many plans allow a few months to submit receipts. The article also notes broader context — U.S. health-care spending was $4.9 trillion in 2023 with out-of-pocket spending rising 7.2% to $505.7 billion — and highlights operational fixes (checking online portals, HR or plan administrator) and eligible expense strategies to reduce forfeitures.

Analysis

Market structure: End-of-year FSA forfeiture (40–50% of accounts, average $436 forfeited in 2023) creates a predictable seasonal demand spike for OTC/eligible healthcare products and pharmacy services. Winners are large omnichannel retailers and pharmacy chains (CVS, WMT, TGT, AMZN) and payment processors (V, MA) that can capture last-minute electronic transactions; losers are small specialty retailers and undercapitalized pharmacy chains with weak FSA acceptance or POS integration.

Risk assessment: Key tail risks are regulatory change (state/federal limits on forfeiture or mandated carryovers), class-action suits over disclosure, and employers shifting to carryover/grace-period designs which would smooth and reduce the spike. Time buckets: immediate (weeks — Dec purchasing spike), short-term (1–6 months — employer plan design announcements/HR communications), long-term (3+ years — rising FSA access and contribution cap to $3,400 in 2026 altering secular demand patterns).

Trade implications: Tactical long exposure to large pharmacies/retailers before early December captures the spike; use small call spreads to limit capital and theta exposure. Pair trades (long CVS or WMT, short RAD) express scale advantage vs weaker operators. Allocate a modest long to payroll/benefits platforms (ADP, PAYX, BNFT) as UX improvements that reduce forfeitures could be monetized through services.

Contrarian angles: The market underestimates value of UX-enabled discovery tools (Benefitfocus/ADP integrations) that can convert forfeited dollars into retained customer spend — this is a multi-year revenue reallocation, not just a seasonal blip. Conversely, if >10% of employers move to automatic carryovers within 12–24 months, the consensus seasonal trade will be muted and timing-sensitive option bets could blow up.

Key Decisions for Investors

• Establish a 2.0% long position in CVS Health (CVS) and a 1.0% long in Walmart (WMT) by Nov 25–Dec 5 to capture year-end FSA-driven OTC/pharmacy volume; plan to trim/sell 50% of these positions by Jan 15 unless employer-design data indicates persistent upside.
• Enter a limited-risk options trade: buy Jan 31 (90-day) call spreads on CVS (size 0.5–1.0% notional) 10–25% OTM to monetize the December spike while capping premium decay; close by Feb 10 at the latest.
• Open a 1.0% short position in Rite Aid (RAD) or pair trade long CVS (2%) / short RAD (1%) reflecting scale and FSA-card acceptance gaps; review after Q4 same-store sales release.
• Build a 0.75–1.5% long position in payroll/benefits tech (ADP, PAYX, and 0.5% in Benefitfocus BNFT) over the next 60 days to capture upside from FSA UX integrations; if within 90 days >10% of large employers announce mandatory carryovers, reduce retail positions by 50% and increase benefits-tech exposure by 25%.